{
  "trial_id": "NCT02248428",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Signed informed consent form",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Able to adhere to the study visit schedule and other protocol requirements",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Diagnosed with active multiple myeloma",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Previously untreated",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Karnofsky performance status(KPS) \u226550\uff08KPS<50 will be allowed if related to bony disease\uff09",
      "label": "unknown",
      "evidence": "quote"
    },
    {
      "criterion": "New York Heart Association(NYHA) functional \u2264class III",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Hypersensitivity to clarithromycin or any of its excipients, erythromycin, or any of the macrolide antibiotics;",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Concomitant administration of cisapride, pimozide, astemizole, terfenadine, ergotamine or dihydroergotamine, simvastatin, lovastatin, and atorvastatin;",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "A history of cholestatic jaundice/hepatic dysfunction associated with prior use of clarithromycin.",
      "label": "unknown",
      "evidence": "quote"
    },
    {
      "criterion": "Impaired renal function,Creatinine \u2265221umol/L\uff1b",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Pregnant or breast feeding females.",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Any condition which places the subject at unacceptable risk if he/she were to participate in the study or confounds the ability to interpret data from the study.",
      "label": "unknown",
      "evidence": "quote"
    }
  ],
  "notes": "Patient has multiple myeloma with recurrent disease and systemic amyloidosis, on hemodialysis for ESRD. She was treated with various regimens including melphalan, prednisone, VAD, thalidomide, and velcade.",
  "_meta": {
    "topic_id": "17",
    "trial_id": "NCT02248428",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}